Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India

Genes and Immunity

Volumn 2, Issue 5, 2001, Pages 248-253

  Choi, E H ^a   Zimmerman, P A ^b,c   Foster, C B ^a   Zhu, S ^a   Kumaraswami, V ^d   Nutman, T B ^b   Chanock, S J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Chitotriosidase; Filariasis; Innate immunity; Mannose binding lectin; Polymorphism

Indexed keywords

ANIMAL; ARTICLE; CHRONIC DISEASE; ELEPHANTIASIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; INDIA; INNATE IMMUNITY; PILOT STUDY; RISK FACTOR; WUCHERERIA BANCROFTI;

ANIMALS; CHRONIC DISEASE; ELEPHANTIASIS, FILARIAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNITY, NATURAL; INDIA; PILOT PROJECTS; POLYMORPHISM, GENETIC; RISK FACTORS; WUCHERERIA BANCROFTI;

EID: 0035433620     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363767     Document Type: Article

References (50)

1. Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis. World Health Organ Tech Rep Ser 1992; 821: 1-71.
2. Lymphatic filariasis: diagnosis and pathogenesis. WHO expert committee on filariasis. Bull World Health Organ 1993; 71: 135-141.
3. Mahanty SRM, Raman U, Jayaraman K, Kumaraswami V, Nutman TB. Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis. Infect Immun 1997; 65: 1742-1747.
4. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000; 405: 847-856.
5. Wang DG, Fan JB, Siao CJ et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998; 280: 1077-1082.
6. Cargill M, Altshuler D, Ireland J et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22: 231-238.
7. Chanock SJ, Foster CB. SNPing away at innate immunity. J Clin Invest 1999, 104: 369-370.
8. Subrahmanyam D, Mehta K, Nelson DS, Rao YV, Rao CK. Immune reactions in human filariasis. J Clin Microbiol 1978; 8: 228-232.
9. Sasazuki T, Ohta N, Kaneoka R, Kojima S. Association between an HLA haplotype and low responsiveness to schistosomal worm antigen in man. J Exp Med 1980; 152: 314s-318s.
10. Chan SH, Dissanayake S, Mak JW et al. HLA and filariasis in Sri Lankans and Indians. Southeast Asian J Trop Med Public Health 1984; 15: 281-286.
11. Meyer CG, Gallin M, Erttmann KD et al. HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci USA 1994; 91: 7515-7519.
12. Murdoch ME, Payton A, Abiose A et al. HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on Onchocerciasis. Hum Immunol 1997; 55: 46-52.
13. Yazdanbakhsh M, Sartono E, Kruize YC et al. HLA and elephantiasis in lymphatic filariasis. Hum Immunol 1995; 44: 58-61.
14. Brattig NW, Tischendorf FW, Reifegerste S, Albiez EJ, Berger J. Differences in the distribution of HLA antigens in localized and generalized form of onchocerciasis. Trop Med Parasitol 1986; 37: 271-275.
15. Abel L, Demenais F, Prata A, Souza AE, Dessein A. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991; 48: 959-970.
16. Yazdanbakhsh M, Abadi K, de Roo M et al. HLA and elephantiasis revisited. Eur J Immunogenet 1997; 24: 439-442.
17. Rodrigues V, Jr., Piper K, Couissinier-Paris P, Bacelar O, Dessein H, Dessein AJ. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes. Infect Immun 1999; 67: 4689-1692.
18. Dessein A. Genetic predisposition to infectious diseases. Med Trop (Mars) 1997; 57: 10-12.
19. Dessein AJ, Hillaire D, Elwali NE et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 1999; 65: 709-721.
20. Marquet S, Abel L, Hillaire D et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996; 14: 181-184.
21. Mohamed-Ali Q, Elwali NE, Abdelhameed AA et al. Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J Infect Dis 1999; 180: 1298-1306.
22. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 1990; 86: 1729-1737.
23. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998; 97: 135-137.
24. London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997; 57: 5001-5003.
25. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
26. Boot RG, Renkema GH, Strijland A, van Zonneveld AJ, Aerts JM. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem 1995; 270: 26252-26256.
27. Boot RG, Renkema GH, Verhoek M et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 1998; 273: 25680-25685.
28. Madsen HO, Garred P, Kurtzhals JA et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994; 40: 37-44.
29. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-3020.
30. Flach J, Pilet PE, Jolles P. What's new in chitinase research? Experientia 1992; 48: 701-716.
31. Collinge DB, Kragh KM, Mikkelsen JD, Nielsen KK, Rasmussen U, Vad K. Plant chitinases. Plant J 1993; 3: 31-40.
32. Wang SH, Zheng HJ, Dissanayake S et al. Evaluation of recombinant chitinase and SXP1 antigens as antimicrofilarial vaccines. Am J Trop Med Hyg 1997; 56: 474-481.
33. Dissanayake S, Perler FB, Xu M et al. Differential recognition of microfilarial chitinase, a transmission-blocking vaccine candidate antigen, by sera from patients with Brugian and Bancroftian filariasis. Am J Trop Med Hyg 1995; 53: 289-294.
34. Adam R, Kaltmann B, Rudin W, Friedrich T, Marti T, Lucius R. Identification of chitinase as the immunodominant filarial antigen recognized by sera of vaccinated rodents. J Biol Chem 1996; 271: 1441-1447.
35. Devaney E. Lectin-binding characteristics of Brugia pahangi microfilariae. Trop Med Parasitol 1985; 36: 25-28.
36. Hoppe HJ, Reid KB. Trimeric C-type lectin domains in host defence. Structure 1994; 2: 1129-1133.
37. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
38. Garred P, Richter C, Andersen AB et al. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol 1997; 46: 204-208.
39. Garred P, Pressler T, Madsen HO et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104: 431-437.
40. Foster CB, Lehrnbecher T, Mol F et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 1998; 102: 2146-2155.
41. Winkler C, Modi W, Smith MW et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-393.
42. Balotta C, Bagnarelli P, Corvasce S et al. Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. J Infect Dis 1999; 180: 285-289.
43. Garcia A, Abel L, Cot M et al. Longitudinal survey of Loa loa filariasis in southern Cameroon: long-term stability and factors influencing individual microfilarial status. Am J Trop Med Hyg 1995; 52: 370-375.
44. Garcia A, Abel L, Cot M et al. Genetic epidemiology of host predisposition microfilaraemia in human loiasis. Trop Med Int Health 1999; 4: 565-574.
45. Garcia A, Marquet S, Bucheton B et al. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am J Trop Med Hyg 1998; 58: 705-709.
46. Garcia A, Cot M, Chippaux JP et al. Genetic control of blood infection levels in human malaria: evidence for a complex genetic model. Am J Trop Med Hyg 1998; 58: 480-488.
47. Knight JC, Udalova I, Hill AV et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
48. Lal RB, Ottesen EA. Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment. J Infect Dis 1988; 158: 1034-1037.
49. Simonsen PE, Dunyo SK. Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens. Trans R Soc Trop Med Hyg 1999; 93: 278-282.
50. Bloch P, Simonsen PE, Weiss N, Nutman TB. The significance of guinea worm infection in the immunological diagnosis of onchocerciasis and bancroftian filariasis. Trans R Soc Trop Med Hyg 1998; 92: 518-521.